This clinical trial is focused on studying the effects of a medication called Tirzepatide on adolescents who have obesity and related health issues. Tirzepatide is a solution for injection that is being tested to see if it can help reduce body mass index (BMI) and improve conditions related to excess weight. The study will compare the effects of Tirzepatide to a placebo, which is a substance with no active medication, to determine its effectiveness.

The purpose of the study is to find out if Tirzepatide can help adolescents achieve a healthier weight and improve their overall health. Participants in the study will receive injections of either Tirzepatide or a placebo once a week. The study will last for a period of up to 18 months, during which time the health and weight of the participants will be closely monitored.

Throughout the study, researchers will look at changes in BMI and any improvements in weight-related health issues. The goal is to see if Tirzepatide can provide significant benefits compared to the placebo. This research is important for understanding how to better manage obesity and its related health problems in young people.